Home NDC 69794-302 FAYUVI
Product NDC 69794-302
11-digit product format 697940302
Labeler code 69794
Product ID 69794-302_453f2a2e-d064-41ba-a715-11285409d478
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name rebisufligene etisparvovec-hopf
Dosage form KIT
Labeler Ultragenyx Pharmaceutical Inc.
Application BLA125845
Marketing category BLA
Marketing start 2026-10-31
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base FAYUVI
Listing expiration 2027-12-31
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 4 · 64 matching rows.
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join FAYUVI REBISUFLIGENE ETISPARVOVEC-HOPF Ultragenyx Pharmaceutical Inc. 996fc33a-26d3-4fae-bd0c-a2edd7764539 2026-10-01 Warnings, Adverse reactions Exact identifier application number: BLA125845 ndc (product): 69794-302
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125845 Fayuvi rebisufligene etisparvovec-hopf 351(a) Rx 2026-10-01
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 69794-302-06 69794030206 1 KIT in 1 CARTON (69794-302-06) * 2 mL in 1 VIAL (69794-300-01) 1 kit 2026-10-31 No No Current